Paratek Pharmaceuticals, Inc. (PRTK) Social Stream
PARATEK PHARMACEUTICALS INC (PRTK) Price Targets From Analysts
Use the tables below to see what analysts covering PARATEK PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 3 | $27 | $10 | $17.333 | $2.23 | 677.26% |
| 2022-02-10 | 3 | $27 | $11 | $17.666 | $2.23 | 692.2% |
| 2022-03-14 | 3 | $27 | $11 | $17 | $2.23 | 662.33% |
| 2022-03-17 | 3 | $22 | $11 | $15.333 | $2.23 | 587.58% |
| 2022-05-04 | 3 | $30 | $11 | $19 | $2.23 | 752.02% |
| 2022-08-08 | 3 | $30 | $11 | $18.5 | $2.23 | 729.6% |
| 2022-11-04 | 3 | $30 | $11 | $18 | $2.23 | 707.17% |
| 2023-01-24 | 2 | $30 | $9 | $19.666 | $2.23 | 781.88% |
| 2023-03-16 | 2 | $30 | $7 | $19 | $2.23 | 752.02% |
| 2023-03-20 | 2 | $30 | $7 | $15.666 | $2.23 | 602.51% |
| 2023-04-17 | 3 | $24 | $7 | $13.666 | $2.23 | 512.83% |
| 2023-05-10 | 3 | $24 | $5 | $13 | $2.23 | 482.96% |
| 2023-05-11 | 3 | $24 | $5 | $11.666 | $2.23 | 423.14% |
| 2023-08-07 | 3 | $24 | $2.15 | $9.433 | $2.23 | 323% |
The Trend in the Analyst Price Target
PRTK's average price target has moved down $7.9 over the prior 21 months.
PRTK reports an average of 669.38% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 1 | 30 | 9.00 | 19.666 | 2.09 | 840.96% |
| 2023-03-16 | 2 | 30 | 7.00 | 19.000 | 1.48 | 1183.78% |
| 2023-03-20 | 3 | 30 | 7.00 | 15.666 | 1.37 | 1043.5% |
| 2023-06-07 | 3 | 24 | 2.15 | 9.433 | 2.26 | 317.39% |
| 2023-08-03 | 3 | 24 | 2.15 | 9.433 | 2.20 | 328.77% |
PRTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 17 months, PRTK's average broker recommendation rating worsened by 1.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTK as an investment opportunity.
- PARATEK PHARMACEUTICALS INC's number of analysts covering the stock is higher than 134.25% of all US stocks.
- PARATEK PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2061.91% of all US stocks.
- In the context of all US stocks, PARATEK PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1766.28% of them.
- PRTK has a higher average analyst price target than 631.31% of Healthcare stocks.
In the Pharmaceutical Products industry, GTHX, AEZS, and MRUS are the three stocks most similar to PARATEK PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PRTK using the data that counts. Try POWR Ratings for free.